BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

915 related articles for article (PubMed ID: 31387169)

  • 1. Mitochondrial dysfunction in high-fat diet-induced nonalcoholic fatty liver disease: The alleviating effect and its mechanism of Polygonatum kingianum.
    Yang XX; Wang X; Shi TT; Dong JC; Li FJ; Zeng LX; Yang M; Gu W; Li JP; Yu J
    Biomed Pharmacother; 2019 Sep; 117():109083. PubMed ID: 31387169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial metabolomic profiling for elucidating the alleviating potential of
    Yang XX; Wei JD; Mu JK; Liu X; Li FJ; Li YQ; Gu W; Li JP; Yu J
    World J Gastroenterol; 2019 Nov; 25(43):6404-6415. PubMed ID: 31798277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jiuzhuan Huangjing Pills relieve mitochondrial dysfunction and attenuate high-fat diet-induced metabolic dysfunction-associated fatty liver disease.
    Mu JK; Zi L; Li YQ; Yu LP; Cui ZG; Shi TT; Zhang F; Gu W; Hao JJ; Yu J; Yang XX
    Biomed Pharmacother; 2021 Oct; 142():112092. PubMed ID: 34449316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatoprotective Effect of Seed Coat ofEuryale ferox Extract in Non-alcoholic Fatty Liver Disease Induced by High-fat Diet in Mice by Increasing IRs-1 and Inhibiting CYP2E1.
    Jian T; Yu C; Ding X; Chen J; Li J; Zuo Y; Ren B; Lv H; Li W
    J Oleo Sci; 2019 Jun; 68(6):581-589. PubMed ID: 31092797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunction in obesity-associated nonalcoholic fatty liver disease: the protective effects of pomegranate with its active component punicalagin.
    Zou X; Yan C; Shi Y; Cao K; Xu J; Wang X; Chen C; Luo C; Li Y; Gao J; Pang W; Zhao J; Zhao F; Li H; Zheng A; Sun W; Long J; Szeto IM; Zhao Y; Dong Z; Zhang P; Wang J; Lu W; Zhang Y; Liu J; Feng Z
    Antioxid Redox Signal; 2014 Oct; 21(11):1557-70. PubMed ID: 24393106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure.
    Zaitone SA; Barakat BM; Bilasy SE; Fawzy MS; Abdelaziz EZ; Farag NE
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):587-600. PubMed ID: 25708949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined treatments with metformin and phosphodiesterase inhibitors alleviate nonalcoholic fatty liver disease in high-fat diet fed rats: a comparative study.
    Heeba GH; El-Deen RM; Abdel-Latif RG; Khalifa MMA
    Can J Physiol Pharmacol; 2020 Aug; 98(8):498-505. PubMed ID: 32083947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated metabolomic profiling for analysis of antilipidemic effects of
    Yang XX; Wei JD; Mu JK; Liu X; Dong JC; Zeng LX; Gu W; Li JP; Yu J
    World J Gastroenterol; 2018 Dec; 24(48):5505-5524. PubMed ID: 30622379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ameliorative effect of nicorandil on high fat diet induced non-alcoholic fatty liver disease in rats.
    Elshazly SM
    Eur J Pharmacol; 2015 Feb; 748():123-32. PubMed ID: 25542756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD).
    Wang Z; Li S; Wang R; Guo L; Xu D; Zhang T; Xu Y; Wang W; Wang M; Gan Z; Wang X
    Mol Med; 2020 Jun; 26(1):54. PubMed ID: 32503411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat.
    Jiang W; Guo MH; Hai X
    World J Gastroenterol; 2016 Dec; 22(46):10180-10188. PubMed ID: 28028366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease.
    Shan W; Gao L; Zeng W; Hu Y; Wang G; Li M; Zhou J; Ma X; Tian X; Yao J
    Cell Death Dis; 2015 Jul; 6(7):e1833. PubMed ID: 26203862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of hydroalcoholic extract of spinach on prevention and treatment of some metabolic and histologic features in a rat model of nonalcoholic fatty liver disease.
    Amirinejad A; Hekmatdoost A; Ebrahimi A; Ranjbaran F; Shidfar F
    J Sci Food Agric; 2020 Mar; 100(4):1787-1796. PubMed ID: 31849065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carnosic acid protects non-alcoholic fatty liver-induced dopaminergic neuron injury in rats.
    Xu T; Zhou J; Zhu J; Zhang S; Zhang N; Zhao Y; Ding C; Shi X; Yao J
    Metab Brain Dis; 2017 Apr; 32(2):483-491. PubMed ID: 27957651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of RKI-1447 in a Mouse Model of Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet and in HepG2 Human Hepatocellular Carcinoma Cells Treated with Oleic Acid.
    Wang J; Jiang W
    Med Sci Monit; 2020 Feb; 26():e919220. PubMed ID: 32026851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phyllanthus Niruri Standardized Extract Alleviates the Progression of Non-Alcoholic Fatty Liver Disease and Decreases Atherosclerotic Risk in Sprague-Dawley Rats.
    Al Zarzour RH; Ahmad M; Asmawi MZ; Kaur G; Saeed MAA; Al-Mansoub MA; Saghir SAM; Usman NS; Al-Dulaimi DW; Yam MF
    Nutrients; 2017 Jul; 9(7):. PubMed ID: 28718838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triterpenoid-rich fraction from Ilex hainanensis Merr. attenuates non-alcoholic fatty liver disease induced by high fat diet in rats.
    Cui WX; Yang J; Chen XQ; Mao Q; Wei XL; Wen XD; Wang Q
    Am J Chin Med; 2013; 41(3):487-502. PubMed ID: 23711137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease.
    Kathirvel E; Morgan K; French SW; Morgan TR
    Nutr Res; 2013 Nov; 33(11):932-41. PubMed ID: 24176233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-naphthoflavone attenuates non-alcoholic fatty liver disease in oleic acid-treated HepG2 hepatocytes and in high fat diet-fed mice.
    Xia H; Zhu X; Zhang X; Jiang H; Li B; Wang Z; Li D; Jin Y
    Biomed Pharmacother; 2019 Oct; 118():109287. PubMed ID: 31401392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatic aldehyde compound cuminaldehyde protects nonalcoholic fatty liver disease in rats feeding high fat diet.
    Haque MR; Ansari SH
    Hum Exp Toxicol; 2019 Jul; 38(7):823-832. PubMed ID: 30974975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.